Compound Detail

CHEMBL4790818

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

O=C(Nc1ccc([N+](=O)[O-])cc1)C(c1ccccc1)N(C(=O)/C=C/c1ccccc1)c1ccccc1

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL4790818
Phase	Preclinical
Structure Type	MOL
InChI Key	DIHAIVCWTLYNOV-LTGZKZEYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

477.5

MW (Da)

6.02

ALogP

HBA

HBD

92.5

PSA (Å²)

0.19

QED

Ro5 Violations

Rot. Bonds

First in Class Prodrug

IC50 4 meas. best 7.89

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
MCF7 CHEMBL387	IC50	7.89	7.89	12.9	1
Unchecked CHEMBL612545	IC50	7.89	7.89	13.0	1
HepG2 CHEMBL395	IC50	7.71	7.71	19.5	1
WI-38 CHEMBL614391	IC50	7.54	7.54	29.1	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
MCF7	IC50	=	12.9	nM	7.89	Anticancer activity against human MCF7 cells assessed as reduction in cell viabi...	31740054
Unchecked	IC50	=	12.97	nM	7.89	Anticancer activity against human NFS-60 cells assessed as reduction in cell via...	31740054
HepG2	IC50	=	19.5	nM	7.71	Anticancer activity against human HepG2 cells assessed as reduction in cell viab...	31740054
WI-38	IC50	=	29.1	nM	7.54	Cytotoxicity against human WI-38 cells assessed as reduction in cell viability b...	31740054

PubMed	DOI	Target Context	# Activities
31740054	10.1016/j.ejmech.2019.111875	Unchecked	4
31740054	10.1016/j.ejmech.2019.111875	WI-38	2
31740054	10.1016/j.ejmech.2019.111875	MCF7	1
31740054	10.1016/j.ejmech.2019.111875	HepG2	1

Data from ChEMBL 36 via Core Engine